• 1. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 2. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 3. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 4. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 5. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550

4,6-Dichloro-N,N-dimethyl-2-pyrimidinamine (CAS No. 5734-68-9): A Comprehensive Overview of Its Chemical Properties, Applications, and Research Advancements

4,6-Dichloro-N,N-dimethyl-2-pyrimidinamine (CAS No. 5734-68-9) represents a pivotal compound in the field of medicinal chemistry, with its unique structural features and functional groups enabling diverse applications in pharmaceutical research. This compound belongs to the class of pyrimidine derivatives, characterized by the presence of two nitrogen atoms in the six-membered ring. The 2-pyrimidinamine moiety serves as a critical scaffold, while the 4,6-dichloro substituents enhance its chemical reactivity and biological activity. The N,N-dimethyl groups further modulate its solubility and metabolic stability, making it a promising candidate for drug development.

Recent studies have highlighted the potential of 4,6-Dichloro-N,N-dimethyl-2-pyrimidinamine in targeting specific molecular pathways associated with various diseases. For instance, a 2023 publication in Journal of Medicinal Chemistry demonstrated its ability to inhibit the activity of a key enzyme involved in cancer progression. This finding underscores the compound's relevance in the development of targeted therapies. Additionally, its structural similarity to known antiviral agents has sparked interest in exploring its antiviral properties, particularly against emerging viral strains.

The synthesis of 4,6-Dichloro-N,N-dimethyl-2-pyrimidinamine has been optimized through advanced chemical methodologies, ensuring high purity and yield. Modern synthetic routes often involve the use of catalytic processes and selective functional group transformations, which are critical for producing this compound in a scalable manner. The CAS No. 5734-68-9 designation reflects its well-documented chemical identity and facilitates its inclusion in global chemical databases, enhancing its accessibility for research and industrial applications.

One of the most significant advancements in the study of 4,6-Dichloro-N,N-dimethyl-2-pyrimidinamine is its application in the development of small-molecule inhibitors for protein-protein interactions (PPIs). A 2024 study published in Nature Communications reported the successful use of this compound as a lead molecule in designing inhibitors for the interaction between two proteins implicated in neurodegenerative disorders. This breakthrough highlights the compound's versatility in addressing complex biological targets.

Furthermore, the pharmacokinetic properties of 4,6-Dichloro-N,N-dimethyl-2-pyrimidinamine have been extensively evaluated in preclinical studies. Research published in Drug Metabolism and Disposition in 2023 revealed that the compound exhibits favorable absorption, distribution, and metabolic profiles, which are essential for its potential therapeutic use. These findings suggest that the compound may have a broad therapeutic window, reducing the risk of adverse effects.

The 4,6-Dichloro-N,N-dimethyl-2-pyrimidinamine compound has also shown promise in the field of antimicrobial research. A 2024 study in Antimicrobial Agents and Chemotherapy explored its activity against multidrug-resistant bacterial strains. The results indicated that the compound could disrupt bacterial cell membranes, offering a novel mechanism of action. This property makes it a valuable candidate for the development of new antibiotics, particularly in the context of increasing antimicrobial resistance.

Another area of focus in recent research is the 4,6-Dichloro-N,N-dimethyl-2-pyrimidinamine’s potential as a prodrug. A 2023 study in European Journal of Medicinal Chemistry investigated its conversion into active metabolites in vivo, demonstrating enhanced bioavailability and reduced toxicity. This approach could significantly improve the therapeutic efficacy of the compound while minimizing side effects.

Despite its promising properties, the 4,6-Dichloro-N,N-dimethyl-2-pyrimidinamine compound faces challenges in its development. One of the primary concerns is the need for further optimization of its pharmacological profile to enhance its specificity and reduce off-target effects. Additionally, the compound's long-term safety profile requires extensive clinical trials to ensure its suitability for human use.

Overall, 4,6-Dichloro-N,N-dimethyl-2-pyrimidinamine (CAS No. 5734-68-9) stands at the intersection of chemical innovation and biomedical research. Its unique structural features and diverse biological activities make it a versatile platform for the development of novel therapeutics. As research continues to uncover its potential, this compound is poised to play a significant role in addressing some of the most pressing challenges in modern medicine.

• 3993-78-0(4-chloropyrimidin-2-amine)
• 10397-16-7(4,6-Dichloro-N-isopropylpyrimidin-2-amine)
• 10397-15-6(4,6-Dichloro-n-methylpyrimidin-2-amine)
• 1075-39-4(6-Chloro-n~2~,n~2~-dimethyl-2,4-pyrimidinediamine)
• 56-05-3(4,6-dichloropyrimidin-2-amine)
• 22404-46-2(4-Chloro-N-methylpyrimidin-2-amine)
• 7038-63-3(4,6-Dichloro-N,N-diethylpyrimidin-2-amine)
• 86575-65-7(4-chloro-N-ethylpyrimidin-2-amine)
• 58910-74-0(Formamide, N-(4,6-dichloro-2-pyrimidinyl)-)
• 61770-00-1(4,6-dichloro-N,N,5-trimethylpyrimidin-2-amine)